N-Nitroso Desisopropyl Selexipag
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Selexipag is used in adults to treat pulmonary arterial hypertension (PAH, high blood pressure in the vessels that carry blood to the lungs) to slow down the worsening of symptoms and reduce the chance of being hospitalized for PAH.Selexipag Nitroso Impurity 2 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Selexipag Nitroso Impurity 2 CAS NO:NA is also Known as N-nitroso Desisopropyl Selexipag and it is Chemically represented as 2-(4-((5,6-Diphenylpyrazin-2-yl)(nitroso)amino)butoxy)-N-(methylsulfonyl)acetamide . Synchemia is the leading manufacturing and exporter of Selexipag Nitroso Impurity 2.We supply Selexipag Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143923 |
| CAS No | NA |
| Mol.F. | C5H13N3O2 |
| Mol.Wt. | 147.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143924 |
| CAS No | 65504-34-9 |
| Mol.F. | C6H13N3O |
| Mol.Wt. | 143.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143925 |
| CAS No | NA |
| Mol.F. | C10H19N3O |
| Mol.Wt. | 197.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143926 |
| CAS No | 2680529-63-7 |
| Mol.F. | C3H9N3O |
| Mol.Wt. | 103.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143927 |
| CAS No | 13256-15-0 |
| Mol.F. | C7H13N3O3 |
| Mol.Wt. | 187.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143928 |
| CAS No | 95732-53-9 |
| Mol.F. | C6H14N2O2 |
| Mol.Wt. | 146.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143929 |
| CAS No | 51938-16-0 |
| Mol.F. | C5H12N2O2 |
| Mol.Wt. | 132.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143930 |
| CAS No | 3121845-17-5 |
| Mol.F. | C9H12N2O4S |
| Mol.Wt. | 244.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143931 |
| CAS No | 1007-19-8 |
| Mol.F. | C7H7ClN2O |
| Mol.Wt. | 170.6 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143932 |
| CAS No | 819-35-2 |
| Mol.F. | C3H5F3N2O |
| Mol.Wt. | 142.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143933 |
| CAS No | NA |
| Mol.F. | C9H12N2O |
| Mol.Wt. | 164.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143934 |
| CAS No | 18907-82-9 |
| Mol.F. | C4H7N3O2 |
| Mol.Wt. | 129.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143935 |
| CAS No | 124485-93-4 |
| Mol.F. | C9H12N2O2 |
| Mol.Wt. | 180.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143936 |
| CAS No | NA |
| Mol.F. | C11H25N3O3Si |
| Mol.Wt. | 275.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143937 |
| CAS No | NA |
| Mol.F. | C7H13N3O |
| Mol.Wt. | 155.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143938 |
| CAS No | NA |
| Mol.F. | C7H12N4O2 |
| Mol.Wt. | 184.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |